Business Standard

Bal Pharma Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Corporate Action-Board to consider Dividend Please refer to our intimation regarding Board Meeting dated 30.04.2024.03/05/2024
Board Meeting Intimation for Notice For The Board Meeting BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of th...Read More30/04/2024
Disclosure Of Statement Of Deviation/Veriation Disclosure of Deviation / variation in utilization of issue proceeds from the ob...Read More18/04/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate We are submitting to the exchange intimation received from our R&T agent i.e Lin...Read More17/04/2024
Compliance With Regulation 40(9) Of SEBI(LODR) Regulations. Compliance certificate as per Regulation 40(9) of SEBI(LODR) Regulations for th...Read More15/04/2024
Disclosures As Per Regulation 31(4) Of SEBI(SAST) Regulations. We are submitting to the exchange disclosures by our promoters as per Regulation...Read More05/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Confirmation as per Regulation 74(5) of SEBI (DP) Regulations for the quarter en...Read More05/04/2024
Regulation 7(3) Certificate For The Financial Year Ended 31.03.2024. Compliance certificate as per Regulation 7(3) of SEBI(LODR) Regulations2015.04/04/2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A <b>Format of Initial Disclosure to be made by an entity identified as a Large Co...Read More02/04/2024
Closure of Trading Window Pursuant to the Code of Conduct of the Company and as per the amended provisions...Read More22/03/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication We are submitting to the exchanges copies of the newspaper advertisements of ab...Read More14/02/2024
Board Meeting Outcome for Unaudited Financial Results For The Quarter And 9 Months Ended 31.12.2023. 1. Taken on record and approved the Un-Audited Standalone and Consolidated Fina...Read More12/02/2024
Unaudited Financial Results For The Quarter Ended 31.12.2023. Unaudited standalone and consolidated Financial results for the quarter and 9 mo...Read More12/02/2024
Board Meeting Intimation for 1)Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended 31.12.2023.2)To Consider Investing Additional Capital In Expanding Its Manufacturing Presence Through A Green Field Project. BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of th...Read More25/01/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication We are submitting to the exchanges newspaper publication of the Notice issued to...Read More21/11/2023
Announcement under Regulation 30 (LODR)-Change in Management We would like to inform the exchanges that Ms.Nicola Neeladri ( DIN # 01997936 )...Read More24/08/2023
Shareholder Meeting / Postal Ballot-Scrutinizers Report We are submitting to the exchanges e-voting results of the postal ballot along ...Read More23/08/2023
Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 30.06.2023. BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of th...Read More01/08/2023
Announcement under Regulation 30 (LODR)-Newspaper Publication We are submitting to the exchange newspaper advertisements of Notice issued to o...Read More31/07/2023
Notice To The Shareholders Reg Transfer Of Shares To IEPF A/C We have circulated the enclosed Notice to all our shareholders whose shares are ...Read More26/07/2023

Load more